Hotaling Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$225K Buy
+3,765
New +$205K 0.1% 106
2022
Q3
Sell
-4,641
Closed -$207K 115
2022
Q2
$207K Buy
4,641
+1,096
+31% +$56.2K 0.09% 117
2022
Q1
$201K Buy
+3,545
New +$185K 0.08% 125
2021
Q2
Sell
-3,125
Closed -$204K 128
2021
Q1
$204K Sell
3,125
-236
-7% -$15.4K 0.09% 109
2020
Q4
$221K Buy
+3,361
New +$198K 0.1% 101
2020
Q2
Sell
-4,300
Closed -$219K 107
2020
Q1
$219K Sell
4,300
-288
-6% -$16.6K 0.16% 91
2019
Q4
$253K Buy
4,588
+31
+0.7% +$1.68K 0.15% 97
2019
Q3
$229K Buy
4,557
+44
+1% +$2.21K 0.15% 97
2019
Q2
$227K Buy
4,513
+29
+0.6% +$1.41K 0.15% 104
2019
Q1
$208K Sell
4,484
-11,098
-71% -$562K 0.14% 113
2018
Q4
$765K Buy
+15,582
New +$886K 0.62% 61

Other funds holding EHC

Hotaling Investment Management's EHC Position: Q4 2022 in Review

Hotaling Investment Management opened a new position in Encompass Health (EHC) in Q4 2022: 3,765 shares worth $225K. The stake represents 0.1% of the portfolio and ranks #106 among its holdings. This is a return to the name: Hotaling Investment Management previously reported a position in EHC as recently as Q2 2022.

Hotaling Investment Management first reported a position in EHC in Q4 2018 and has held it in 11 quarters since. The position peaked at $765K in Q4 2018. 377 funds tracked by Wall St. Rank hold EHC as of Q4 2022.

  • Hotaling Investment Management held 3,765 shares of Encompass Health worth $225K as of Q4 2022.
  • Encompass Health was a new Hotaling Investment Management position in Q4 2022.
  • Encompass Health made up 0.1% of Hotaling Investment Management's portfolio in Q4 2022, its #106 holding.
  • Hotaling Investment Management first reported a position in Encompass Health in Q4 2018 and has held it in 11 quarters since.
  • Hotaling Investment Management's Encompass Health position peaked at $765K in Q4 2018.
  • 377 funds tracked by Wall St. Rank held Encompass Health as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.